stockaxis

Anlon Healthcare Ltd.

IPO Details
  • Issue Type Book building
  • Price range
  • Market Lot
  • Total Equity Shares 14000000
  • Face Value Rs. 10
  • Listing Date
IPO Timeline
Opening date
Closing date
Listing Date

IPO Details

We are a R&D driven chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates (“Pharma Intermediate”) which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients (“APIs”) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (“FDF”) such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Our products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API. Our active pharmaceutical ingredient products are manufactured in accordance with Indian and international pharmacopeia standards such as IP, BP, EP, JP, USP.

Projects

1. Project Name: Funding capital expenditure requirements for Proposed Expansion

Project Cost: 307.2

3. Project Name: Funding the working capital requirements of our Company

Project Cost: 431.5

Promoters

Prmoters Name
Prmoters Holdings
  • Pre Share Capital: 28000000
  • Pre Promoter Holding: 70.26
  • Offer to Public: 14000000
  • Post Share Capital:
  • Post Promoter Holding:

Registrar

Data not availble

Lead Managers

Subscription Details